Long-term outcome of kidney function in patients with ANCA-associated vasculitis

被引:7
|
作者
Sachez-Alamo, Beatriz [1 ,2 ]
Moi, Laura [3 ]
Bajema, Ingeborg [4 ]
Berden, Annelies [5 ]
Flossmann, Oliver [6 ]
Hruskova, Zdenka [7 ]
Jayne, David [8 ]
Wester-Trejo, Maria [9 ]
Wallquist, Carin [10 ]
Westman, Kerstin [11 ]
机构
[1] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
[2] Hosp Univ Sureste, Dept Nephrol, Madrid, Spain
[3] Univ Hosp Lausanne, Lausanne Univ, Dept Med, Div Immunol & Allergy, Lausanne, Switzerland
[4] Dept Pathol, Groningen, Netherlands
[5] Maasstad Hosp, Dept Rheumatol & Clin Immunol, Rotterdam, Netherlands
[6] Royal Berkshire Hosp, Dept Nephrol, Reading, England
[7] Charles Univ Prague, Gen Hosp Prague, Fac Med 1, Dept Nephrol, Prague, Czech Republic
[8] Univ Cambridge, Dept Med, Cambridge, England
[9] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands
[10] Skane Univ, Hosp Malmo, Dept Nephrol, Malmo, Sweden
[11] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
关键词
ANCA-associated vasculitis; end-stage kidney disease; kidney histology scores; prognosis; transplantation; ANTIBODY-ASSOCIATED VASCULITIS; HISTOPATHOLOGICAL CLASSIFICATION; SPANISH REGISTRY; RENAL VASCULITIS; GLOMERULONEPHRITIS; BIOPSY; SURVIVAL; PROPOSAL; WEGENER; TRIALS;
D O I
10.1093/ndt/gfae018
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Kidney involvement is common in anti-neutrophil cytoplasm antibody-associated vasculitis (AAV) and the prognosis is determined by the severity of kidney damage. This study focused on long-term kidney outcomes, defining possible risk factors and comparing the performance of three different histological classifications to predict outcomes for patients with AAV. Methods. The dataset included 848 patients with newly diagnosed AAV who participated in seven randomized controlled trials (RCTs) (1995-2012). Follow-up information was obtained from questionnaires sent to the principal investigators of the original RCTs. Results. The cumulative incidence of end-stage kidney disease (ESKD) at 5 and 10 years was 17% and 22%, respectively. Patients who developed ESKD had reduced patient survival compared with those with preserved kidney function (hazard ratio 2.8, P < .001). Comparing patients with AAV and kidney involvement with a matched general population, patients with AAV had poor survival outcomes, even in early stages of chronic kidney disease. The main cause of death was infection followed by cardiovascular disease in patients developing ESKD and malignancy in those who did not. Some 34% of patients with initial need for dialysis recovered kidney function after treatment. Thirty-five out of 175 in need of kidney replacement therapy (KRT) during follow-up received a kidney transplant with good outcome; there was 86% patient survival at 10 years. In the subcohort of 214 patients with available kidney biopsies, three scoring systems were tested: the Berden classification, the Renal Risk Score and the Mayo Clinic Score. The scores highlighted the importance of normal glomeruli and severe glomerulosclerosis on kidney survival (P < .001 and P = .001, respectively). The Renal Risk Score demonstrated a moderate prediction of kidney survival (area under the curve 0.79; standard error 0.03, 95% confidence interval 0.71-0.83). Conclusions Early diagnosis of AAV is extremely important. Even milder forms of kidney involvement have an impact on the prognosis. Patients in need of KRT had the lowest survival rates, but kidney transplantation has shown favorable outcomes for eligible AAV patients. The three histologic scoring systems were all identified as independent prognostic factors for kidney outcome.
引用
收藏
页码:1483 / 1493
页数:11
相关论文
共 50 条
  • [21] Clinical outcomes of ANCA-associated vasculitis in elderly patients
    Haris, Agnes
    Polner, Kalman
    Aranyi, Jozsef
    Braunitzer, Henrik
    Kaszas, Ilona
    Mucsi, Istvan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (08) : 1595 - 1600
  • [22] Evolution of Therapy for ANCA-Associated Vasculitis with Kidney Involvement
    Rajasekaran, Arun
    Rizk, Dana V.
    KIDNEY360, 2023, 4 (12): : 1794 - 1805
  • [23] Advances in Therapy for ANCA-Associated Vasculitis
    Geetha, Duvuru
    Seo, Philip
    CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (06) : 509 - 515
  • [24] Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
    McClure, Mark E.
    Zhu, Yajing
    Smith, Rona M.
    Gopaluni, Seerapani
    Tieu, Joanna
    Pope, Tasneem
    Kristensen, Karl Emil
    Jayne, David R. W.
    Barrett, Jessica
    Jones, Rachel B.
    RHEUMATOLOGY, 2021, 60 (03) : 1491 - 1501
  • [25] Long-term Outcome and Efficacy of Cyclophosphamide Therapy in Japanese Patients with ANCA-associated Microscopic Polyangiitis: A Retrospective Study
    Nakaya, Izaya
    Yahata, Mayumi
    Takahashi, Satoko
    Sasajima, Tomomi
    Sakuma, Tsutomu
    Shibagaki, Yugo
    Soma, Jun
    INTERNAL MEDICINE, 2013, 52 (22) : 2503 - 2509
  • [26] Immunopathogenesis of ANCA-Associated Vasculitis
    Kronbichler, Andreas
    Lee, Keum Hwa
    Denicolo, Sara
    Choi, Daeun
    Lee, Hyojeong
    Ahn, Donghyun
    Kim, Kang Hyun
    Lee, Ji Han
    Kim, HyungTae
    Hwang, Minha
    Jung, Sun Wook
    Lee, Changjun
    Lee, Hojune
    Sung, Haejune
    Lee, Dongkyu
    Hwang, Jaehyuk
    Kim, Sohee
    Hwang, Injae
    Kim, Do Young
    Kim, Hyung Jun
    Cho, Geonjae
    Cho, Yunryoung
    Kim, Dongil
    Choi, Minje
    Park, Junhye
    Park, Junseong
    Tizaoui, Kalthoum
    Li, Han
    Smith, Lee
    Koyanagi, Ai
    Jacob, Louis
    Gauckler, Philipp
    Shin, Jae Il
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 27
  • [27] Pathology of ANCA-associated vasculitis
    Ferrario, Franco
    Vanzati, Alice
    Pagni, Fabio
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (05) : 652 - 658
  • [28] Biomarkers in ANCA-Associated Vasculitis
    Lally, Lindsay
    Spiera, Robert F.
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (10)
  • [29] Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA
    Garo, Florian
    Aglae, Cedric
    Perrochia, Helene
    Ahmadpoor, Pedram
    Daniel, Laurent
    Moranne, Olivier
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2022, 12 (01): : 73 - 80
  • [30] The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial
    Odler, Balazs
    Riedl, Regina
    Geetha, Duvuru
    Szpirt, Wladimir M.
    Hawley, Carmel
    Uchida, Lisa
    Wallace, Zachary S.
    Walters, Giles
    Muso, Eri
    Tesar, Vladimir
    Pusey, Charles D.
    Little, Mark A.
    Merkel, Peter A.
    Walsh, Michael
    Jayne, David R. W.
    Kronbichler, Andreas
    KIDNEY INTERNATIONAL, 2025, 107 (03) : 558 - 567